enGene Holdings Inc.
enGene Holdings Inc. (ENGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ENGN · as of Jun 8, 2026
Key Statistics
Explore enGene Holdings Inc. Data
engn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 44.4%
The ENGN analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $7.00, representing +326.83% upside from the current price of $1.64.
Competitors & Peers
engn competitorsENGN
ACIU
ALT
AMRN
ANNX
ANROStock Performance
Full HistoryAbout enGene Holdings Inc.
enGene Holdings Inc. through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues an…
what is engene holdings inc. · engn stock overview · engene holdings inc. company profile · who is engene holdings inc. ceo · engn NASDAQ · engene holdings inc. headquarters · engene holdings inc. business segments
About Stock Overview & Key Data
enGene Holdings Inc. (ENGN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 1, 2022. As of the latest trading session, ENGN stock price is $1.64, with a market capitalization of $84.0M. The stock has returned -51.04% over the past 12 months and -81.84% year-to-date.
According to 9 Wall Street analysts, the consensus rating for enGene Holdings Inc. stock is Hold, with an average 12-month price target of $7.00. In fiscal year 2025, enGene Holdings Inc. reported revenue of — and net income of -$117.3M. For detailed data — including enGene Holdings Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, enGene Holdings Inc. (ENGN) stock price is $1.64. The stock is traded on NASDAQ under the ticker symbol ENGN. The 52-week range is $1.40 – $12.25.